Public health expenditure and spatial interactions in a decentralized national health system

One of the limitations of cross-country health expenditure analysis refers to the fact that the financing, the internal organization and political restraints of health care decision-making are country-specific and heterogeneous. Yet, a potential solution is to examine the influence of such effects in those countries that have undertaken decentralization processes. In such a setting, it is possible to examine potential expenditure spillovers across the geography of a country as well as the influence of the political ideology of regional incumbents on public health expenditure. This paper examines the determinants of public health expenditure within Spanish region-states (Autonomous Communities, ACs), most of them subject to similar financing structures although exhibiting significant heterogeneity as a result of the increasing decentralization, region-specific political factors along with different use of health care inputs, economic dimension and spatial interactions

Public health expenditure and spatial interactions in a decentralized national health system

One of the limitations of cross-country health expenditure analysis refers to the fact that the financing, the internal organization and political restraints of health care decision-making are country-specific and heterogeneous. Yet, a potential solution is to examine the influence of such effects in those countries that have undertaken decentralization processes. In such a setting, it is possible to examine potential expenditure spillovers across the geography of a country as well as the influence of the political ideology of regional incumbents on public health expenditure. This paper examines the determinants of public health expenditure within Spanish region-states (Autonomous Communities, ACs), most of them subject to similar financing structures although exhibiting significant heterogeneity as a result of the increasing decentralization, region-specific political factors along with different use of health care inputs, economic dimension and spatial interactions

Public health expenditure and spatial interactions in a decentralized national health system

One of the limitations of cross-country health expenditure analysis refers to the fact that the financing, the internal organization and political restraints of health care decision-making are country-specific and heterogeneous. Yet, a potential solution is to examine the influence of such effects in those countries that have undertaken decentralization processes. In such a setting, it is possible to examine potential expenditure spillovers across the geography of a country as well as the influence of the political ideology of regional incumbents on public health expenditure. This paper examines the determinants of public health expenditure within Spanish region-states (Autonomous Communities, ACs), most of them subject to similar financing structures although exhibiting significant heterogeneity as a result of the increasing decentralization, region-specific political factors along with different use of health care inputs, economic dimension and spatial interactions

Diversity and regional inequalities: Assessing the outcomes of the Spanish 'System of Health Care Services'

The consolidation of a universal health system coupled with a process of regionaldevolution characterise the institutional reforms of the National Health System(NHS) in Spain in the last two decades. However, scarce empirical evidence hasbeen reported on the effects of both changes in health inputs, outputs andoutcomes, both at the country and at the regional level. This paper examinesthe empirical evidence on regional diversity, efficiency and inequality ofthese changes in the Spanish NHS using cross-correlation, panel data andexpenditure decomposition analysis. Results suggest that besides significantheterogeneity, once we take into account region-specific needs there is evidenceof efficiency improvements whilst inequalities in inputs and outcomes, althoughmore visible , do not appear to have increased in the last decade. Therefore,the devolution process in the Spanish Health System offers an interesting casefor the experimentation of health reforms related to regional diversity butcompatible with the nature of a public NHS, with no sizeable regionalinequalitiest.

Health care management autonomy: Evidence from the Catalonian hospital sector in a decentralised Spain

The organisation of inpatient care provision has undergone significant reform in many southern European countries. Overall across Europe, public management is moving towards the introduction of more flexibility and autonomy . In this setting, the promotion of the further decentralisation of health care provision stands out as a key salient policy option in all countries that have hitherto had a traditionally centralised structure. Yet, the success of the underlying incentives that decentralised structures create relies on the institutional design at the organisational level, especially in respect of achieving efficiency and promoting policy innovation without harming the essential principle of equal access for equal need that grounds National Health Systems (NHS). This paper explores some of the specific organisational developments of decentralisation structures drawing from the Spanish experience, and particularly those in the Catalonia. This experience provides some evidence of the extent to which organisation decentralisation structures that expand levels of autonomy and flexibility lead to organisational innovation while promoting activity and efficiency. In addition to this pure managerial decentralisation process, Spain is of particular interest as a result of the specific regional NHS decentralisation that started in the early 1980 s and was completed in 2002 when all seventeen autonomous communities that make up the country had responsibility for health care services.Already there is some evidence to suggest that this process of decentralisation has been accompanied by a degree of policy innovation and informal regional cooperation. Indeed, the Spanish experience is relevant because both institutional changes took place, namely managerial decentralisation leading to higher flexibility and autonomy- alongside an increasing political decentralisation at the regional level. The coincidence of both processes could potentially explain why some organisation and policy innovation resulting from policy experimentation at the regional level might be an additional featureto take into account when examining the benefits of decentralisation.

Organisational innovations and health care decentralisation: A perspective from Spain

Recent policy developments in public health care systems lead to a greater diversity in health care. Decentralisation, either geographically or at an institutional level, is the key force, because it encourages innovation and local initiatives in health care provision. The devolution of responsibilities allows for a sort of de-construction of the status quo by changing both organizational forms and service provision. The new organizations enjoy greater freedom in the way they pay their staff, and are judged according to their results. These organizations may retain financial surpluses, develop spin-off companies and commission a range of specialised services (such as Diagnostic and Treatment Centres in UK) from providers outside the institutional setting in order to have more access to capital markets. However this diversity may generate a feeling of lack of commitment to a national health service and ultimately a loss of social cohesion. By fiscal decentralisation to regional authorities or planned delegation of financial agreements to the providers, financial incentives are more explicit and may seem to place profit-making above a commitment to better health care. An evaluation of the myths and realities of the decentralization process is needed. Here, I offer an assessment pros and cons of the decentralization process of health care in Spain, drawing on the experience of regional reforms from the pioneering organisational innovations implemented in Catalonia in 1981, up to the observed dispersion of health care spending per capita among regions at present.

How important are tobacco prices in the propensity to start and quit smoking? An analysis of smoking histories from the Spanish National Health Survey

This paper analyses the effect of tobacco prices on the propensity tostart and quit smoking using a pool of the 1993, 1995 and 1997 editionsof the Spanish National Health Surveys. The estimates for severalparametric models of the hazard rate for starting and quitting suggestthat i) The public health measures applied as of 1992 have had asignificative effect on both reducing the hazard of starting andincreasing the hazard of quitting, ii) Prices have a very weak effect onthe hazard of starting in the male population and no significant effectin the female population, iii) The price floor of cigarrettes, proxiedby the average price of a pack of black cigarrettes, has a significanteffect on the quitting hazard which is robust across specifications andapplies to both men and women. The implied price elasticity of the timeup to quitting is situated around -1.4.

The evolution of inequity in the access to health care in Spain: 1987-2001

This paper reports an analysis of the evolution of equity in access to health care in Spain over the period 1987-2001, a time span covering the development of the modern Spanish National Health System. Our measures of access are the probabilities of visiting a doctor, using emergency services and being hospitalised. For these three measures we obtain indices of horizontal inequity from microeconometric models of utilization that exploit the individual information in the Spanish National Health Surveys of 1987 and 2001. We find that by 2001 the system has improved in the sense that differences in income no longer lead to different access given the same level of need. However, the tenure of private health insurance leads to differences in access given the same level of need, and its contribution to inequity has increased over time, both because insurance is more concentrated among the rich and because the elasticity of utilization for the three services has increased too.

Market structure and hospital efficiency: Evaluating potential effects of deregulation in a national health service

In this article we examine the potential effect of market structureon hospital technical efficiency as a measure of performance controlled byownership and regulation. This study is relevant to provide an evaluationof the potential effects of recommended and initiated deregulation policiesin order to promote market reforms in the context of a European NationalHealth Service. Our goal was reached through three main empirical stages.Firstly, using patient origin data from hospitals in the region of Cataloniain 1990, we estimated geographic hospital markets through the Elzinga--Hogartyapproach, based on patient flows. Then we measured the market level ofconcentration using the Herfindahl--Hirschman index. Secondly, technicaland scale efficiency scores for each hospital was obtained specifying aData Envelopment Analysis. According to the data nearly two--thirds of thehospitals operate under the production frontier with an average efficiencyscore of 0.841. Finally, the determinants of the efficiency scores wereinvestigated using a censored regression model. Special attention waspaid to test the hypothesis that there is an efficiency improvement in morecompetitive markets. The results suggest that the number of competitors inthe market contributes positively to technical efficiency and there is someevidence that the differences in efficiency scores are attributed toseveral environmental factors such as ownership, market structure andregulation effects.

Traducción de documentos médicos pertenecientes al NorthShore University Health System

El presente trabajo consiste en la selección, análisis y traducción de 8 documentos con especialidad médica publicados por la institución sanitaria NorthShore University Health System. La elección de esta temática en la elaboración de este proyecto está vinculada al hecho de que en la actualidad trabajo como intérprete con especialidad en medicina para esta organización. Durante el año y medio que llevo en este organismo, he podido observar que existe un gran número de artículos, formularios, folletos informativos, consentimientos quirúrgicos y un largo etcétera que no están traducidos al castellano, cuestión que dificulta enormemente la comunicación, entendimiento y funcionamiento de las relaciones entre los pacientes, familiares y el equipo médico. El NorthShore University Health System tiene un Departamento de Interpretación con 12 intérpretes de castellano en plantilla, 3 intérpretes de ruso, 2 intérpretes de polaco, un intérprete de coreano y un intérprete de árabe. Lamentablemente, el NorthShore no posee un Departamento de Traducción para la traducción de los documentos destinados a los pacientes. El Departamento de Interpretación, bajo la dirección de la supervisora Erika Erdbeer, contrata a una agencia de traducción certificada por la American Translators Association para la traducción de estos documentos. Este proceso supone un alto costo para el Departamento de Interpretación en particular, y para la institución sanitaria en general. De igual modo, el volumen de documentos en necesidad de ser traducidos es sustancialmente más elevado que los recursos económicos disponibles para la traducción de los mismos, y esto supone que no haya presupuesto para traducir muchos de los textos esenciales. En términos generales, esta situación va en detrimento de los derechos e intereses de todos aquellos pacientes que tienen un conocimiento limitado del inglés.A su vez, la labor de los intérpretes se hace muy dificultosa debido al hecho de que en numerosas ocasiones tenemos que realizar traducciones a la vista (sight translate) de una variedad de permisos, formularios, documentos legales, hojas de consentimiento y un largo etcétera que deberían estar traducidos al castellano, y que dada la amplia carga de trabajo que tenemos, no podemos emplear el tiempo necesario para ofrecer al paciente una traducción oral de calidad. Por consiguiente, en un intento por mejorar esta situación, y con el propósito de ofrecer a la comunidad hispanoparlante que acude a esta institución unos servicios de calidad, hemos querido diseñar un proyecto basado en la selección y traducción de los documentos médicos más utilizados por los pacientes hispanoparlantes. Para el proceso de traducción hemos utilizado la herramienta de Traducción Asistida SDL Trados Studio 2009, con la intención de crear una memoria de traducción que pueda ser utilizada en futuros proyectos. Las traducciones realizadas en este trabajo serán publicadas y distribuidas en los pertinentes departamentos del NorthShore. Como paso previo a la publicación de estos documentos, Erika Erdbeer, supervisora del Departamento de Interpretación, enviará las traducciones a la agencia de traducción MetaPhrasis para ser corregidas y revisadas. Por motivos de responsabilidad legal, el NorthShore University Health System tiene la obligación de contratar traductores certificados por la American Translators Association. En la actualidad la autora de este proyecto se encuentra en el proceso de sacar dicha certificación, por lo que será necesario enviar las traducciones para que sean corregidas y revisadas a un traductor/a certificado. Tras la revisión y corrección de los documentos el NorthShore University Health System procederá a la publicación y distribución de los mismos tan pronto lo estime conveniente.

The burden of hospital malnutrition in Spain: methods and development of the PREDyCES® study

It is well known that hospital malnutrition is a highly prevalent condition associated to increase morbidity and mortality as well as related healthcare costs. Although previous studies have already measured the prevalence and/or costs of hospital nutrition in our country, their local focus (at regional or even hospital level) make that the true prevalence and economic impact of hospital malnutrition for the National Health System remain unknown in Spain. The PREDyCES® (Prevalence of hospital malnutrition and associated costs in Spain) study was aimed to assess the prevalence of hospital malnutrition in Spain and to estimate related costs. Some aspects made this study unique: a) It was the first study in a representative sample of hospitals of Spain; b) different measures to assess hospital malnutrition (NRS2002, MNA as well as anthropometric and biochemical markers) where used both at admission and discharge and, c) the economic consequences of malnutrition where estimated using the perspective of the Spanish National Health System.

Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain

To compare the cost and effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) versus combined oral contraception (COC) and progestogens (PROG) in first-line treatment of dysfunctional uterine bleeding (DUB) in Spain. STUDY DESIGN: A cost-effectiveness and cost-utility analysis of LNG-IUS, COC and PROG was carried out using a Markov model based on clinical data from the literature and expert opinion. The population studied were women with a previous diagnosis of idiopathic heavy menstrual bleeding. The analysis was performed from the National Health System perspective, discounting both costs and future effects at 3%. In addition, a sensitivity analysis (univariate and probabilistic) was conducted. RESULTS: The results show that the greater efficacy of LNG-IUS translates into a gain of 1.92 and 3.89 symptom-free months (SFM) after six months of treatment versus COC and PROG, respectively (which represents an increase of 33% and 60% of symptom-free time). Regarding costs, LNG-IUS produces savings of 174.2-309.95 and 230.54-577.61 versus COC and PROG, respectively, after 6 months-5 years. Apart from cost savings and gains in SFM, quality-adjusted life months (QALM) are also favourable to LNG-IUS in all scenarios, with a range of gains between 1 and 2 QALM compared to COC and PROG. CONCLUSIONS: The results indicate that first-line use of the LNG-IUS is the dominant therapeutic option (less costly and more effective) in comparison with first-line use of COC or PROG for the treatment of DUB in Spain. LNG-IUS as first line is also the option that provides greatest health-related quality of life to patients.

Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain

To compare the cost and effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) versus combined oral contraception (COC) and progestogens (PROG) in first-line treatment of dysfunctional uterine bleeding (DUB) in Spain. STUDY DESIGN: A cost-effectiveness and cost-utility analysis of LNG-IUS, COC and PROG was carried out using a Markov model based on clinical data from the literature and expert opinion. The population studied were women with a previous diagnosis of idiopathic heavy menstrual bleeding. The analysis was performed from the National Health System perspective, discounting both costs and future effects at 3%. In addition, a sensitivity analysis (univariate and probabilistic) was conducted. RESULTS: The results show that the greater efficacy of LNG-IUS translates into a gain of 1.92 and 3.89 symptom-free months (SFM) after six months of treatment versus COC and PROG, respectively (which represents an increase of 33% and 60% of symptom-free time). Regarding costs, LNG-IUS produces savings of 174.2-309.95 and 230.54-577.61 versus COC and PROG, respectively, after 6 months-5 years. Apart from cost savings and gains in SFM, quality-adjusted life months (QALM) are also favourable to LNG-IUS in all scenarios, with a range of gains between 1 and 2 QALM compared to COC and PROG. CONCLUSIONS: The results indicate that first-line use of the LNG-IUS is the dominant therapeutic option (less costly and more effective) in comparison with first-line use of COC or PROG for the treatment of DUB in Spain. LNG-IUS as first line is also the option that provides greatest health-related quality of life to patients.

Traducción de documentos médicos pertenecientes al NorthShore University Health System

El presente trabajo consiste en la selección, análisis y traducción de 8 documentos con especialidad médica publicados por la institución sanitaria NorthShore University Health System. La elección de esta temática en la elaboración de este proyecto está vinculada al hecho de que en la actualidad trabajo como intérprete con especialidad en medicina para esta organización. Durante el año y medio que llevo en este organismo, he podido observar que existe un gran número de artículos, formularios, folletos informativos, consentimientos quirúrgicos y un largo etcétera que no están traducidos al castellano, cuestión que dificulta enormemente la comunicación, entendimiento y funcionamiento de las relaciones entre los pacientes, familiares y el equipo médico. El NorthShore University Health System tiene un Departamento de Interpretación con 12 intérpretes de castellano en plantilla, 3 intérpretes de ruso, 2 intérpretes de polaco, un intérprete de coreano y un intérprete de árabe. Lamentablemente, el NorthShore no posee un Departamento de Traducción para la traducción de los documentos destinados a los pacientes. El Departamento de Interpretación, bajo la dirección de la supervisora Erika Erdbeer, contrata a una agencia de traducción certificada por la American Translators Association para la traducción de estos documentos. Este proceso supone un alto costo para el Departamento de Interpretación en particular, y para la institución sanitaria en general. De igual modo, el volumen de documentos en necesidad de ser traducidos es sustancialmente más elevado que los recursos económicos disponibles para la traducción de los mismos, y esto supone que no haya presupuesto para traducir muchos de los textos esenciales. En términos generales, esta situación va en detrimento de los derechos e intereses de todos aquellos pacientes que tienen un conocimiento limitado del inglés.A su vez, la labor de los intérpretes se hace muy dificultosa debido al hecho de que en numerosas ocasiones tenemos que realizar traducciones a la vista (sight translate) de una variedad de permisos, formularios, documentos legales, hojas de consentimiento y un largo etcétera que deberían estar traducidos al castellano, y que dada la amplia carga de trabajo que tenemos, no podemos emplear el tiempo necesario para ofrecer al paciente una traducción oral de calidad. Por consiguiente, en un intento por mejorar esta situación, y con el propósito de ofrecer a la comunidad hispanoparlante que acude a esta institución unos servicios de calidad, hemos querido diseñar un proyecto basado en la selección y traducción de los documentos médicos más utilizados por los pacientes hispanoparlantes. Para el proceso de traducción hemos utilizado la herramienta de Traducción Asistida SDL Trados Studio 2009, con la intención de crear una memoria de traducción que pueda ser utilizada en futuros proyectos. Las traducciones realizadas en este trabajo serán publicadas y distribuidas en los pertinentes departamentos del NorthShore. Como paso previo a la publicación de estos documentos, Erika Erdbeer, supervisora del Departamento de Interpretación, enviará las traducciones a la agencia de traducción MetaPhrasis para ser corregidas y revisadas. Por motivos de responsabilidad legal, el NorthShore University Health System tiene la obligación de contratar traductores certificados por la American Translators Association. En la actualidad la autora de este proyecto se encuentra en el proceso de sacar dicha certificación, por lo que será necesario enviar las traducciones para que sean corregidas y revisadas a un traductor/a certificado. Tras la revisión y corrección de los documentos el NorthShore University Health System procederá a la publicación y distribución de los mismos tan pronto lo estime conveniente.

Development of a population-based cost-effectiveness model of chronic graft versus host disease in Spain

Chronic graft-versus-host disease (cGvHD) is the leading cause of late nonrelapse mortality (transplant-related mortality) after hematopoietic stem cell transplant. Given that there are a wide range of treatment options for cGvHD, assessment of the associated costs and efficacy can help clinicians and health care providers allocate health care resources more efficiently. OBJECTIVE: The purpose of this study was to assess the cost-effectiveness of extracorporeal photopheresis (ECP) compared with rituximab (Rmb) and with imatinib (Imt) in patients with cGvHD at 5 years from the perspective of the Spanish National Health System. METHODS: The model assessed the incremental cost-effectiveness/utility ratio of ECP versus Rmb or Imt for 1000 hypothetical patients by using microsimulation cost-effectiveness techniques. Model probabilities were obtained from the literature. Treatment pathways and adverse events were evaluated taking clinical opinion and published reports into consideration. Local data on costs (2010 Euros) and health care resources utilization were validated by the clinical authors. Probabilistic sensitivity analyses were used to assess the robustness of the model. RESULTS: The greater efficacy of ECP resulted in a gain of 0.011 to 0.024 quality-adjusted life-year in the first year and 0.062 to 0.094 at year 5 compared with Rmb or Imt. The results showed that the higher acquisition cost of ECP versus Imt was compensated for at 9 months by greater efficacy; this higher cost was partially compensated for ( 517) by year 5 versus Rmb. After 9 months, ECP was dominant (cheaper and more effective) compared with Imt. The incremental cost-effectiveness ratio of ECP versus Rmb was 29,646 per life-year gained and 24,442 per quality-adjusted life-year gained at year 2.5. Probabilistic sensitivity analysis confirmed the results. The main study limitation was that to assess relative treatment effects, only small studies were available for indirect comparison. CONCLUSION: ECP as a third-line therapy for cGvHD is a more cost-effective strategy than Rmb or Imt.